Menu

Image of the Day: DNA Knitter

Researchers show how condensin complexes organize DNA in real time.

Feb 27, 2018
The Scientist Staff, The Scientist Staff

A condensin protein (red) binds DNA (green) and extrudes a DNA loop.CEES DEKKER LAB, KAVLI INSTITUTE OF NANOSCIENCE

Researchers at Kavli Institute of Delft University and EMBL Heidelberg have filmed a protein apparatus manipulating the shape of DNA. In the video, a condensin complex remains bound at the stem of a piece of DNA, which it pulls into a loop. This mechanism is vital to the cell’s ability to neatly package meters-long strands of DNA base pairs into compact chromosomes only a few micrometers in size.

Mahipal Ganji, a biophysicist at Delft University, and colleagues reported in Science on February 22 that they first tethered two ends of a piece of DNA to a surface and observed the condensin complex as it moved along the strand, pulling DNA into a loop at a rate of about 0.6 kilobase pairs per second.

M. Ganji et al., “Real-time imaging of DNA loop extrusion by condensin,” Science, doi:10.1126/science.aar7831, 2018.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!